TABLE 1 North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2 North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3 North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4 North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5 North America Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16 North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26 North America Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27 US Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28 US Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29 US Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30 US Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31 US Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32 US Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33 Canada Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34 Canada Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35 Canada Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36 Canada Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37 Canada Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38 Canada Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39 Mexico Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40 Mexico Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41 Mexico Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42 Mexico Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43 Mexico Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44 Mexico Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45 Rest of North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46 Rest of North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47 Rest of North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48 Rest of North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49 Rest of North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50 Rest of North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51 Key information – AbbVie, Inc.
TABLE 52 Key Information – Pfizer, Inc.
TABLE 53 Key Information – Amgen, Inc.
TABLE 54 Key Information – Novartis AG
TABLE 55 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 56 Key Information – Viatris, Inc.
TABLE 57 key information – Bausch Health Companies, Inc.
TABLE 58 Key Information – Sanofi S.A.
TABLE 59 Key Information - Merck & Co., Inc.
TABLE 60 Key Information – Bristol-Myers Squibb Company
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Arthritic Therapeutic Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Arthritic Therapeutic Market
FIG 4 Porter’s Five Forces Analysis - Arthritic Therapeutic Market
FIG 5 North America Arthritic Therapeutic Market share, by Application, 2022
FIG 6 North America Arthritic Therapeutic Market share, by Application, 2030
FIG 7 North America Arthritic Therapeutic Market, by Application, 2019 - 2030, USD Million
FIG 8 North America Arthritic Therapeutic Market share, by Product Type, 2022
FIG 9 North America Arthritic Therapeutic Market share, by Product Type, 2030
FIG 10 North America Arthritic Therapeutic Market, by Product Type, 2019 - 2030, USD Million
FIG 11 North America Arthritic Therapeutic Market share, by Country, 2022
FIG 12 North America Arthritic Therapeutic Market share, by Country, 2030
FIG 13 North America Arthritic Therapeutic Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: Amgen, Inc.
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Viatris, Inc.
FIG 20 SWOT Analysis: Bausch Health Companies, Inc.
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Merck & Co., Inc.
FIG 23 SWOT Analysis: Bristol-Myers Squibb Company
Unique Offerings 